Case report reveals a rapid viral load reduction in a pregnant individual treated with long-acting HIV medication, highlighting potential benefits of injectable therapies.
We report the first case to quantitatively demonstrate a rapid and substantial viral load reduction using long-acting cabotegravir and rilpivirine in the third trimester of pregnancy. This case underscores the challenges some pregnant individuals face with daily oral ART and the potential role of long acting injectables in select scenarios.
No takes yet. Share an insight, caveat, or question.
Kazanji et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: